‘United by Unique': How Saudi Arabia is transforming cancer care in the Gulf
Today is World Cancer Day, and the theme for the next two years is 'United by Unique,' which prioritizes patient-centric care and puts people at the heart of the conversation.
Saudi Arabia is leading the way in this regard, through the Proton Beam Therapy Centre and the new Oncology Center of Excellence, which will be built in Riyadh. Both facilities aim to drive forward patient outcomes and experiences through innovation.
United in innovation and care
Riyadh's Oncology Center of Excellence was announced just this week by Johns Hopkins Aramco Healthcare. The center will focus on treating breast, colorectal, and prostate cancers, which are three of the most diagnosed cancers in the region. Since 2014, when Saudi Aramco and Johns Hopkins Medicine collaborated in establishing JHAH to pioneer health innovation in Saudi Arabia and the wider region, they have launched over 50 knowledge-sharing programs in a range of specialisms including oncology, cardiology, and neurology.
A unique approach to cancer treatment
Cancer treatment is evolving, and proton therapy is among the most advanced solutions available today. Unlike conventional radiation therapy, which can affect surrounding healthy tissue, proton beam therapy delivers highly targeted radiation with millimeter precision. This precision reduces side effects and improves outcomes, making it particularly effective for treating tumors in sensitive areas such as the brain, spine, and head and neck, as well as in children.
Kingdom's oncologists and medical researchers now have access to groundbreaking technology
Saudi Arabia's Proton Beam Therapy Centre is evidence of the country's commitment to cutting-edge healthcare solutions. As the first facility of its kind in the region, it welcomes 1,700 patients annually, offering an alternative to specialized care in Europe or the US for GCC residents. This marks a major milestone in medical self-sufficiency and regional accessibility, but the true impact of the Proton Beam Therapy Centre is best seen in the stories of those whose lives have been changed by its capabilities.
Transforming lives, one patient at a time
These centers are symbols of collaboration, bringing together global expertise and local talent to deliver world-class cancer care. Through partnerships with leading international medical institutions, Saudi Arabia is ensuring that its healthcare professionals remain at the cutting edge of medical advancements.
Similarly, Saudi Arabia's oncologists and medical researchers now have access to groundbreaking technology that allows them to push the boundaries of cancer treatment, participate in international clinical trials, and contribute to global oncology advancements.
Thanks to these centers, families no longer have to consider the stress and cost of seeking treatment in far-away locations where language and culture are potential barriers. Now, they receive world-class care without leaving the GCC region, ensuring continuity of support from loved ones while benefiting from the latest in precision medicine.
Moreover, both facilities are designed to serve both Saudi citizens and international patients, reinforcing the Kingdom's ambition to become a global hub for specialized healthcare. By integrating state-of-the-art treatment with holistic patient care, the center embodies the principles of Vision 2030 — emphasizing well-being, innovation, and sustainability
A future built on hope and investment
As Saudi Arabia accelerates its investments in precision medicine and advanced healthcare infrastructure, the Proton Beam Therapy Centre and Oncology Centre of Excellence represent the country's progress and promise, reflecting the Kingdom's vision of becoming a leader in medical innovation, not just for its own people but for the world.
Saudi Arabia's message is clear: The Kingdom is united by its unique commitment to transforming cancer care and providing hope for a healthier future.
• Dr. Faisal Al-Dahmashi, assistant deputy minister for hospital services, Saudi Ministry of Health
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Leaders
27-06-2025
- Leaders
In Photos: GCC Marks the International Day Against Drug Abuse, Illicit Trafficking
Jasem Mohamed Albudaiwi, Secretary General of the Gulf Cooperation Council (GCC), emphasized the utmost priority given by GCC member states to combating drugs, explaining that this commitment stems from their belief in protecting societies and enhancing the security and safety of citizens. During the celebration of the International Day Against Drug Abuse and the Gulf Anti-Drug Week, Albudaiwi addressed attendees, including representatives from the Ministries of Interior and relevant officials from GCC member states. He remarked, 'This occasion embodies the commitment of the GCC member states to continue collective and joint Gulf action.' A Unified Strategy for Drug Control Albudaiwi highlighted the Gulf Strategy for Combating Drugs (2025 – 2028) as a comprehensive framework. He explained, 'This strategy is based on key pillars, including reducing the supply and demand for drugs.' The strategy aims to dry up sources of drugs while promoting alternative development and enhancing the Gulf legislative system. He added, 'Combating drugs is a collective responsibility that requires integrated action, sustained effort, and close cooperation.' This approach involves collaboration between governments, societies, and individuals to effectively address drug-related issues. Albudaiwi underscored the vital role of families and society in drug prevention. He stated, 'They constitute the first line of defense against drugs through conscious upbringing, open dialogue, and continuous care.' Schools, media, religious leaders, and civil society institutions also play crucial roles in spreading awareness. He further emphasized, 'The family has a significant and valuable role in providing emotional and social support.' This support creates a stable environment that boosts the self-confidence of recovering individuals and encourages them to rebuild their lives. Supporting Recovery and Reintegration The Secretary General affirmed the importance of integrating recovering addicts into society. He noted, 'The GCC states have been keen to establish hospitals, centres, and institutions dedicated to this matter.' These facilities provide treatment and rehabilitation programs, ensuring active participation in society. Albudaiwi expressed pride in the cooperation with strategic partners across GCC member states, saying, 'We are keen to bolster these partnerships to ensure coordination and integration at the regional and international levels.' This collaboration aims to build safe, drug-free societies that protect future generations from the dangers of drug abuse. Short link : Post Views: 16
Saudi Gazette
01-05-2025
- Saudi Gazette
New Parkinson's Pump therapy introduced at King's College Hospital London in Dubai
King's College Hospital London in Dubai has heralded new hope for Parkinson's patients by becoming the first to perform subcutaneous levodopa (fos-levodopa) pump therapy on the youngest Parkinson's patient in the UAE and the MENA region. Diagnosed with Parkinson's disease at the age of only 30, the patient lived with the disorder for 14 years and had been entirely dependent on three caregivers for assistance. This treatment marks a giant breakthrough in the care of Parkinson's patients, granting them new prospective enhancements to the patient's quality of life. The Foslevodopa pump therapy was introduced to the Middle East by King's College Hospital Dubai. The continuous delivery of levodopa through the patient's skin via this pump resembles that of an insulin pump for diabetes. Dosing of the drug is individualized, according to the needs of that particular patient. The specialists, namely Dr. Vinod Metta and Prof. Ray Chaudhuri, ensure that the therapy suits the condition of the patient. With the foslevodopa pump, patients can regain some of their independence and carry out daily tasks — never mind fasting during Ramadan — that previously, due to their condition, would have posed quite a challenge. "Personalized care and individualized dosing are critical in Parkinson's treatment," commented Dr. Vinod Metta, Consultant Interventional Neurologist and Parkinson's Specialist at King's College Hospital London in Dubai. "With the Foslevodopa pump, patients can take back control of the disease, regain their independence, and improve upon their quality of life." The procedure was performed at the Parkinson's Center of Excellence in King's College Hospital, Dubai, a regional center of excellence for movement disorders. The center offers world-class diagnostic and treatment innovations and multidisciplinary support to Parkinson's patients and their families while ensuring patient-centered care. Prof. Ray Chaudhuri, who is the professor of neurology and movement disorders at King's College Hospital London, said: "This is a defining moment for Parkinson's care in the area. Foslevodopa is a major step forward in personalized therapy, allowing patients to receive the best possible care." King's Parkinson's Centre of Excellence: Leading the future of Parkinson's care King's Parkinson's Centre of Excellence in Dubai is under the aegis of UK-trained Parkinson's specialists, including Dr. Vinod Metta and Prof. Ray Chaudhuri. The center operates via personalized treatment plans supported by a multidisciplinary team that includes nurses, physiotherapists, speech therapists, dieticians, neuroradiologists, and occupational therapists. Since its founding under Dr. Metta, King's Parkinson's Centre of Excellence has treated over 1,000 patients with Parkinson's across the Gulf Cooperation Council countries. For more information about the foslevodopa/foscarbidopa pump treatment, please contact King's Parkinson's Centre of Excellence: Ms. Therese Masagnay : Ms. Clarissa Sanglian : Research Studies & Clinical Trials Coordinator: This breakthrough treatment offers new hope for Parkinson's patients in the UAE and beyond.
Saudi Gazette
01-05-2025
- Saudi Gazette
Dubai unveils new Parkinson's Pump at King's College Hospital London in Dubai
King's College Hospital London in Dubai has heralded new hope for Parkinson's patients by becoming the first to perform subcutaneous levodopa (fos-levodopa) pump therapy on the youngest Parkinson's patient in the UAE and the MENA region. Diagnosed with Parkinson's disease at the age of only 30, the patient lived with the disorder for 14 years and had been entirely dependent on three caregivers for assistance. This treatment marks a giant breakthrough in the care of Parkinson's patients, granting them new prospective enhancements to the patient's quality of life. The Foslevodopa pump therapy was introduced to the Middle East by King's College Hospital Dubai. The continuous delivery of levodopa through the patient's skin via this pump resembles that of an insulin pump for diabetes. Dosing of the drug is individualized, according to the needs of that particular patient. The specialists, namely Dr. Vinod Metta and Prof. Ray Chaudhuri, ensure that the therapy suits the condition of the patient. With the foslevodopa pump, patients can regain some of their independence and carry out daily tasks — never mind fasting during Ramadan — that previously, due to their condition, would have posed quite a challenge. "Personalized care and individualized dosing are critical in Parkinson's treatment," commented Dr. Vinod Metta, Consultant Interventional Neurologist and Parkinson's Specialist at King's College Hospital London in Dubai. "With the Foslevodopa pump, patients can take back control of the disease, regain their independence, and improve upon their quality of life." The procedure was performed at the Parkinson's Center of Excellence in King's College Hospital, Dubai, a regional center of excellence for movement disorders. The center offers world-class diagnostic and treatment innovations and multidisciplinary support to Parkinson's patients and their families while ensuring patient-centered care. Prof. Ray Chaudhuri, who is the professor of neurology and movement disorders at King's College Hospital London, said: "This is a defining moment for Parkinson's care in the area. Foslevodopa is a major step forward in personalized therapy, allowing patients to receive the best possible care." King's Parkinson's Centre of Excellence: Leading the future of Parkinson's care King's Parkinson's Centre of Excellence in Dubai is under the aegis of UK-trained Parkinson's specialists, including Dr. Vinod Metta and Prof. Ray Chaudhuri. The center operates via personalized treatment plans supported by a multidisciplinary team that includes nurses, physiotherapists, speech therapists, dieticians, neuroradiologists, and occupational therapists. Since its founding under Dr. Metta, King's Parkinson's Centre of Excellence has treated over 1,000 patients with Parkinson's across the Gulf Cooperation Council countries. For more information about the foslevodopa/foscarbidopa pump treatment, please contact King's Parkinson's Centre of Excellence: Ms. Therese Masagnay : Ms. Clarissa Sanglian : Research Studies & Clinical Trials Coordinator: This breakthrough treatment offers new hope for Parkinson's patients in the UAE and beyond.
